Erebouni Medical Center
Medical Journal Erebouni

Double – Blind , Randomized, Parallel, Placebo Controlled Study Examining the Effect of Cross- Linked Polyelectrolyte (CLP) in Heart Failure Patients with Chronic Kidney Disease


DATE – 2009 -2011

Name of the specialist – Hayrapetyan G.G.

Role – Principal Investigator
– International Multicenter double-blind placebo – controlled research (number of protocol CTST - 21)

Jointly participating Organization – Sorbent Therapeutics (, Julie Iwashita, Inc. 710 Lakeway Drive, Suite 290 Sunnyvalley, Ca 94085 USA, USA)

Result – effectiveness of CLP during cardiac insufficiency with chronic renal insufficiency is proved

Publications – scientific article in European Journal of Heart Failure, 2014

In accordance with the "Law of Copyright and Related Rights" when copying or reproduction of materials posted on this site, specify the source - the Web site of the Erebouni Medical Center - is highly requested.
Back to top